Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach

This study is ongoing, but not recruiting participants.

Study NCT00075465 Information provided by National Cancer Institute (NCI)

First Received: January 9, 2004 Last Updated: July 23, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Gastric Cancer

Additional conditions recognized in this trial

Adenocarcinoma
Stomach Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Epirubicin

More general drug interventions related to this trial

Sponsors listed in this trial